Difficulty: Medium
Average Score: 78%
Practice
The following drugs when used as monotherapy in the management of hypertension are likely to be less effective in Afro-Caribbean than in white patients:
Correct answer
A
Rationale
The correct answer is A) Atenolol. In the context of managing hypertension in Afro-Caribbean patients, atenolol is less effective compared to other antihypertensive drugs. This is due to the fact that Afro-Caribbean individuals tend to have a higher prevalence of salt-sensitive hypertension, which is less responsive to beta-blockers like atenolol.
Diltiazem (option B) and Amlodipine (option D) are calcium channel blockers, which are generally effective in treating hypertension in Afro-Caribbean patients. These medications are recommended as first-line agents in this population due to their efficacy and safety profile.
Bendroflumethiazide (option C) is a thiazide diuretic commonly used in the management of hypertension. While thiazide diuretics may have reduced efficacy in some populations, there is no specific data suggesting that they are less effective in Afro-Caribbean patients.
Educationally, understanding the nuances of drug efficacy in different ethnic populations is crucial in providing personalized and effective care to patients. By recognizing the variations in drug response based on genetic and physiological factors, healthcare providers can make informed decisions to optimize treatment outcomes.
Diltiazem (option B) and Amlodipine (option D) are calcium channel blockers, which are generally effective in treating hypertension in Afro-Caribbean patients. These medications are recommended as first-line agents in this population due to their efficacy and safety profile.
Bendroflumethiazide (option C) is a thiazide diuretic commonly used in the management of hypertension. While thiazide diuretics may have reduced efficacy in some populations, there is no specific data suggesting that they are less effective in Afro-Caribbean patients.
Educationally, understanding the nuances of drug efficacy in different ethnic populations is crucial in providing personalized and effective care to patients. By recognizing the variations in drug response based on genetic and physiological factors, healthcare providers can make informed decisions to optimize treatment outcomes.